These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26703747)

  • 1. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
    Brivio S; Cadamuro M; Fabris L; Strazzabosco M
    J Clin Med; 2015 Dec; 4(12):2028-41. PubMed ID: 26703747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
    Vaquero J; Guedj N; Clapéron A; Nguyen Ho-Bouldoires TH; Paradis V; Fouassier L
    J Hepatol; 2017 Feb; 66(2):424-441. PubMed ID: 27686679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells.
    Techasen A; Loilome W; Namwat N; Dokduang H; Jongthawin J; Yongvanit P
    Asian Pac J Cancer Prev; 2012; 13 Suppl():115-8. PubMed ID: 23480772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.
    Cadamuro M; Morton SD; Strazzabosco M; Fabris L
    Transl Gastrointest Cancer; 2013 Jul; 2(3):130-144. PubMed ID: 28989865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.
    Brivio S; Cadamuro M; Fabris L; Strazzabosco M
    Gene Expr; 2018 Mar; 18(1):31-50. PubMed ID: 29070148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
    Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
    Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma.
    Zhang D; Li H; Jiang X; Cao L; Wen Z; Yang X; Xue P
    J Hematol Oncol; 2017 Oct; 10(1):170. PubMed ID: 29084594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.
    Brivio S; Cadamuro M; Strazzabosco M; Fabris L
    World J Hepatol; 2017 Mar; 9(9):455-468. PubMed ID: 28396716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.
    Cadamuro M; Stecca T; Brivio S; Mariotti V; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1435-1443. PubMed ID: 28757170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma.
    Sawanyawisuth K; Sashida G; Sheng G
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
    Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
    Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
    Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.
    Yang H; Lu X; Liu Z; Chen L; Xu Y; Wang Y; Wei G; Chen Y
    Oncotarget; 2015 Mar; 6(8):6310-25. PubMed ID: 25749036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.
    Qian Y; Yao W; Yang T; Yang Y; Liu Y; Shen Q; Zhang J; Qi W; Wang J
    Hepatology; 2017 Oct; 66(4):1165-1182. PubMed ID: 28574228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
    Merino-Azpitarte M; Lozano E; Perugorria MJ; Esparza-Baquer A; Erice O; Santos-Laso Á; O'Rourke CJ; Andersen JB; Jiménez-Agüero R; Lacasta A; D'Amato M; Briz Ó; Jalan-Sakrikar N; Huebert RC; Thelen KM; Gradilone SA; Aransay AM; Lavín JL; Fernández-Barrena MG; Matheu A; Marzioni M; Gores GJ; Bujanda L; Marin JJG; Banales JM
    J Hepatol; 2017 Jul; 67(1):72-83. PubMed ID: 28237397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.